Cargando…
Oncogenic fusion protein FGFR2-PPHLN1: Requirements for biological activation, and efficacy of inhibitors
AIM OF STUDY: Chromosomal translocations such as t(10;12)(q26,q12) are associated with intrahepatic cholangiocarcinoma, a universally fatal category of liver cancer. This translocation creates the oncogenic fusion protein of Fibroblast Growth Factor Receptor 2 joined to Periphilin 1. The aims of thi...
Autores principales: | Li, Fangda, Meyer, April N., Peiris, Malalage N., Nelson, Katelyn N., Donoghue, Daniel J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7451725/ https://www.ncbi.nlm.nih.gov/pubmed/32854034 http://dx.doi.org/10.1016/j.tranon.2020.100853 |
Ejemplares similares
-
Oncogenic fusion protein BCR-FGFR1 requires the breakpoint cluster region-mediated oligomerization and chaperonin Hsp90 for activation
por: Peiris, Malalage N., et al.
Publicado: (2020) -
Oncogenic driver FGFR3-TACC3 requires five coiled-coil heptads for activation and disulfide bond formation for stability
por: Wang, Clark G., et al.
Publicado: (2023) -
BCR: a promiscuous fusion partner in hematopoietic disorders
por: Peiris, Malalage N., et al.
Publicado: (2019) -
Proteomic analysis reveals dual requirement for Grb2 and PLCγ1 interactions for BCR-FGFR1-Driven 8p11 cell proliferation
por: Peiris, Malalage N., et al.
Publicado: (2022) -
Oncogenic driver FGFR3-TACC3 is dependent on membrane trafficking and ERK signaling
por: Nelson, Katelyn N., et al.
Publicado: (2018)